Clinical Trial Update: A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic gastroesophageal junction or gastric cancer has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-02-14